Management of laryngeal chondroradionecrosis: A single-center experience.

Autor: Levin EG; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ritter A; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Bachar G; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mizrachi A; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Shoffel-Havakuk H; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kurman N; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Popovtzer A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Hamzany Y; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Publikováno v: Head & neck [Head Neck] 2025 Jan; Vol. 47 (1), pp. 300-308. Date of Electronic Publication: 2024 Aug 13.

Long-term complications associated with the management of sinonasal malignancies: a single center experience.

Autor: Levin EG; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Tzelnick S; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Yaacobi D; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel., Vainer I; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel., Mizrachi A; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Popovtzer A; Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Soudry E; Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Publikováno v: Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale [Acta Otorhinolaryngol Ital] 2023 Jun; Vol. 43 (3), pp. 203-211.

Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers.

Autor: Gilboa M; Infectious Disease Unit, Sheba Medical Centre, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Tal I; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Infection Control and Prevention Unit, Sheba Medical Center, Israel., Levin EG; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Infection Control and Prevention Unit, Sheba Medical Center, Israel., Segal S; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Infection Control and Prevention Unit, Sheba Medical Center, Israel., Belkin A; Infectious Disease Unit, Sheba Medical Centre, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Zilberman-Daniels T; Infectious Disease Unit, Sheba Medical Centre, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Biber A; Infectious Disease Unit, Sheba Medical Centre, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Rubin C; Infection Control and Prevention Unit, Sheba Medical Center, Israel., Rahav G; Infectious Disease Unit, Sheba Medical Centre, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Regev-Yochay G; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Infection Control and Prevention Unit, Sheba Medical Center, Israel.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2022 Oct; Vol. 43 (10), pp. 1433-1438. Date of Electronic Publication: 2021 Sep 23.

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine.

Autor: Levy I; The Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel., Levin EG; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.; Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel., Olmer L; Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel., Regev-Yochay G; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.; Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel., Agmon-Levin N; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.; Clinical Immunology, Angioedema and Allergy Unit, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel., Wieder-Finesod A; The Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel., Indenbaum V; Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel., Herzog K; ARC Innovation Center, Tel Hashomer, Ramat Gan 52621, Israel., Doolman R; The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel., Asraf K; The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel., Halperin R; The Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel., Lustig Y; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.; ARC Innovation Center, Tel Hashomer, Ramat Gan 52621, Israel., Rahav G; The Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Jul 30; Vol. 10 (8). Date of Electronic Publication: 2022 Jul 30.

Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours.

Autor: Margalit O; Department of Oncology, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel., Shacham-Shmueli E; Department of Oncology, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel. Electronic address: Einat.shmueli@sheba.health.gov.il., Itay A; Department of Oncology, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel., Berger R; Department of Oncology, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel., Halperin S; Department of Oncology, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel., Jurkowicz M; Department of Oncology, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel., Levin EG; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel; The Infectious Diseases Unit, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel., Olmer L; Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel., Regev-Yochay G; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel; The Infectious Diseases Unit, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel., Lustig Y; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel; The Infectious Diseases Unit, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel., Rahav G; Sackler Faculty of Medicine, Tel-Aviv University, P.O.B 39040, Ramat Aviv, Tel Aviv, Israel; The Infectious Diseases Unit, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat Gan, Israel.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jun; Vol. 168, pp. 51-55. Date of Electronic Publication: 2022 Apr 16.